- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Covid-19 related death rates escalating in India and even Non-Covid-19 deaths may surge
The most significant thing India has done is a relatively quicker 21-day nation-wide lock-down. That could help us stem the epidemic, reducing both morbidity and mortality related to Covid-19. Though deaths among the recorded cases in India is 3.3% as against 6% globally, but it may change drastically in the future looking at the current trend. India recorded its first Covid-19 death only on 12th March. Deaths started peaking since 31st March and now there are average 20 deaths daily, with 32 and 33 deaths on 8th and 9th April respectively.
It is important to understand that, the deaths happening today are from those who were infected 14 days back (WHO) 1, means on 27th March when total diagnosed Covid-19 cases were just 794. This can be the least being at a 7-day lag if the medical treatment facilities are compromised 2, – that means on 3rd April, when the diagnosed Covid-19 cases were 2781 and in that sense the death rate gets much higher 249 out of 794 = 31% or 249 out of 2781 = 9%. So calculated death rate comes to somewhere between 9 to 31%.
We can also put a correction factor in calculating Case Fatality Rates (CFR) or death rate. As on 27th March there were only cumulative 20 deaths and as on 3rd April, there were cumulative 86 deaths; which may have occurred from among those Covd-19 patients that were detected one or two weeks prior to that. If we deduct these numbers respectively from total of 249 deaths till 10th April, that results in to 229 (249-20) deaths occurring from the Covid-19 patients as on 27th March or 163 (249-86) deaths as on 3rd April. The respective death rates then is either 29% with 14-day lag or 6% with 7-day lag.
The other most important issue is inadequate Covid-19 testing. Despite the WHO's mandate of test-test and test as the most important strategy to prevent the Coronavirus infection in the community, India has done a precious little. Till April 10th, India has tested only a total of 1,61,330 samples from 1,47,034 individuals for Coronavirus infection 3, way lower than most countries globally, but the capacity is getting enhanced. Major impediments faced by eligible people to get tests being done are – either facing inconvenience getting the tests at public laboratories/centres those offering tests free of charge or cost of Rs.4500/- at private laboratories. Now after yesterday's direction by the Supreme Court of India on a Public Interest Litigation (PIL), the Covid-19 testing will be free of charge to the patients whether they go to public or private labs. 4 However, the mechanism will have to be worked out on reimbursement of Covid-19 testing cost to the private laboratories by the Government. We are eagerly waiting for the rollout of Rapid Antibody Tests; which is stuck despite its approval by the ICMR last week.
Our official webpage https://www.mygov.in/Covid-19 is updated on daily basis, with often a day's lag-time. Another India-specific website that seems to be more updated is https://www.covid19india.org/ and matches that with worldometers. In India-specific information, there is no division on number of critical or serious Covid-19 patients for India and this a serious lapse in reporting.
Global Active Cases = 1219967 | Global Closed Cases = 479868 | Total cases | |||
Mild Cases | Critical cases | Recovered | Deaths | ||
Global | 1170136 (96%) | 49831 (4%) | 376184 (79%) | 102684 (21%) | 1698835 |
India | 6577 | ?? | 774 (76%) | 249 (24%) | 7600 |
India | 6565 | ?? | 642 (73%) | 239 (27%) | 7446 |
General medicine supply was a serious challenge that we still face due to breach in supply-chain mechanism at different stages, though the same is getting toned up day by day. Primary medical care is totally at bay, whereas secondary and tertiary medical care is severely compromised.
In Italy, statistical analysis was done to see the impact of Covid-19 on other medical care. One can conjure with the notion that because the health system is operating at full capacity it may mistakenly record deaths that are outlying in nature, for instance heart attacks, or car accidents – incidents that do not receive timely attention and deaths occur because of the delays in an over-stretched health system. 6 Sizeable indirect deaths had happened in Italy. We must learn from the lessons of Italy and we must make efforts to avert deaths among non-Covid 19 patients, as the care for other critical cases is already severely compromised and may worsen further. Hospital bed occupancies and especially that of ICUs are drastically low due to several reasons – like
a) Hospitals in government as well as private sectors have been directed to minimize their bed occupancy and keep ICU beds and ventilators free for possible inflow of Covid-19 patients
b) Effect of lock-down that results in restricted mobility of patients seeking emergency healthcare
c) Healthcare staff issues, as they can not commute and practicing social-distancing
d) Closure-orders by authorities to lock-down hospitals on detection of even a single healthcare staff with Covid-19 infection.
The indirect deaths, especially of non-Covid-19 patients will surface only after few months to a year. We should make a proactive planning to avert that crisis. Let Covid-19 not be blamed in the history for manifold deaths in non-Covid-19 patients.
Dr. Ishwar Gilada, is Consultant in HIV and Infectious Diseases, Unison Medicare & Research Centre, President AIDS Society of India and Governing Council Member, International AIDS Society
The first person to raise the alarm against AIDS in India(1985), detect HIV infections in India (December 1985) and to start India?s first AIDS Clinic(1986) at the government-run JJ Hospital, Mumbai, Dr Ishwar Gilada is a globally acclaimed HIV expert, credited with bringing India on the AIDS control map of the world. He is the President, AIDS Society of India (ASI) and Secretary General, Peoples Health Organisation-India(PHO) and Governing Council member of International AIDS Society (H.Qs.Geneva). After medical school at Government Medical College, Aurangabad, he sub-specialized in Skin and STDs with an acclaimed dissertation: "Pattern of STDs among Hijras (transgenders)? (1986) that also fetched him Diplomate of American Board of Sexology. He then became the first Indian to receive HIV training at San Francisco General Hospital and University of Medicine and Dentistry, New Jersey (1987). To tackle medico-social problems of the downtrodden, he established PHO, (formerly Indian Health Organization); the premier NGO that spearheaded India?s HIV awareness campaign and sensitized governments and people about the impending epidemic. PHO is acclaimed for its HIV intervention and projects for sex-workers (Saheli Project) and for PMTCT (PHO-Wadia model) were replicated at several places globally and been part of the UNAIDS Best Practices. The US-India Business Council named PHO the most outstanding Indian NGO(1997). OY Millennium Films, Finland featured his work in ?Saheli-a friend in need? that received Prix Italia 2001 Award. He has toiled hard for abolition of Devadasi system (cult-based prostitution) and controlling child prostitution in India from 1982 to 2000. He had initiated, supervised and evaluated 38 AIDS projects in 7 Indian states; worked as consultant for American Foundation for AIDS Research, World Vision International, USAID; evaluated Zambia's National STD/AIDS Control programme. Till date, he addressed over 3750 meetings and training programmes in India and in several high HIV burden African nations. He has 78 awards to his credit. The Junior Chamber International, USA conferred on him "The Outstanding Young Person of the World" award at Glasgow (1995). He was awarded the coveted Annemarie Madison International Award in Munich and was termed ?the Indian Machinegun against AIDS?(1999). Among several firsts, he started India's first comprehensive HIV clinic, Unison Medicare and Research Centre,Mumbai(1995), that manages more than 7000 patients. It was declared HIV care model for resource-poor settings at the 12th International AIDS Conference (IAC), Geneva and was replicated in India and Africa. He served as National AIDS Committee Joint Secretary(1995-1997), on AIDS Society in Asia and Pacific(ASAP) Governing Board(1992-1994), was AIDS Advisor for Goa and Uttar Pradesh states(1995-1999), and was on Global AIDS Policy Coalition and AIDS and Reproductive Health Network boards under Dr Jonathan Mann(1992-2000). He founded Asian Solidarity against AIDS-ASAA(1991), was its Secretary till 2004. From 1993-2008, he was Editor-Publisher of AIDS ASIA for ASAA, Asia?s first AIDS newsletter; which received the Best NGO Magazine award (1999, 2000, 2003) by the Association of Business Communicators of India. He is one of the founders and is Secretary General of Organized Medicine Academic Guild ? an apex body of professional medical organizations in India, established in 2018. One of his seminal contributions, in strengthening India?s AIDS response, in 38 years of professional career, is training thousands of students, doctors, nurses, social workers and counselors in HIV-care. He is one of the founders of AIDS Society of India; which is a professional body of HIV physicians and researchers in India, established on lines of International AIDS Society (IAS). He has published/presented 275 scientific papers globally including IACs from 1989 and International AIDS Society (IAS) Science conferences from 2001, Plenary at IAC-Amsterdam (1992), authored chapters on AIDS/STDs and sex-workers. He had organized and chaired World Congress on AIDS, Mumbai(1990), 12 national AIDS conferences in different cities of India and 11 satellite seminars at IACs. He has been IAS member since 1989 and elected to its Governing Council to represent Asia-Pacific in 2018 for four years. His bids were shortlisted for International AIDS Conferences twice (2013,2019) as he is trying hard to get one to India for the first time. He has championed the cause of HIV treatment access in ?patents versus patients? fight globally. Today India meets 92% of global requirements of HIV treatment. He has been great human rights activists in fighting stigma and discrimination faced by people living with HIV and marginalized communities. The first Goan HIV positive person Dominic D?souza who was incarcerated in isolation in 1989 was released and the Goa Public Health act 1985 was repealed as a result of Dr.Gilada?s initiatives.